{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T11:46:53Z","timestamp":1789559213076,"version":"build-2803163510"},"reference-count":67,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2012,12,28]],"date-time":"2012-12-28T00:00:00Z","timestamp":1356652800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0053035","type":"journal-article","created":{"date-parts":[[2012,12,28]],"date-time":"2012-12-28T22:23:06Z","timestamp":1356733386000},"page":"e53035","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":14,"title":["HIV Protease Inhibitors Do Not Cause the Accumulation of Prelamin A in PBMCs from Patients Receiving First Line Therapy: The ANRS EP45 \u201cAging\u201d Study"],"prefix":"10.1371","volume":"7","author":[{"given":"Sophie","family":"Perrin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Cremer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Faucher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Reynes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Dellamonica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00eblle","family":"Micallef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Solas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Lacarelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Stretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise","family":"Kaspi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9e","family":"Robaglia-Schlupp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corine Nicolino-Brunet Catherine","family":"Tamalet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"L\u00e9vy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Poizot-Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Cau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrice","family":"Roll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2012,12,28]]},"reference":[{"key":"ref1","first-page":"16321","article-title":"Structural organization of the human gene encoding nuclear lamin A and nuclear lamin C. J Biol Chem","volume":"268","author":"F Lin","year":"1993"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1152\/physrev.00047.2005","article-title":"Nuclear lamins: laminopathies and their role in premature ageing","volume":"86","author":"JL Broers","year":"2006","journal-title":"Physiol Rev"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1101\/gad.1652708","article-title":"Nuclear lamins: major factors in the structural organization and function of the nucleus and chromatin","volume":"22","author":"T Dechat","year":"2008","journal-title":"Genes Dev"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/j.1582-4934.2008.00676.x","article-title":"Nuclear lamins: key regulators of nuclear structure and activities","volume":"13","author":"M Prokocimer","year":"2009","journal-title":"J Cell Mol Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.1073\/pnas.89.7.3000","article-title":"Nucleoplasmic localization of prelamin A: implications for prenylation-dependent lamin A assembly into the nuclear lamina","volume":"89","author":"RJ Lutz","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"13049","DOI":"10.1073\/pnas.192460799","article-title":"Zmpste24 deficiency in mice causes spontaneous bone fractures, muscle weakness, and a prelamin A processing defect","volume":"99","author":"MO Bergo","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1042\/BJ20041359","article-title":"Prelamin A endoproteolytic processing in vitro by recombinant Zmpste24","volume":"387","author":"DP Corrigan","year":"2005","journal-title":"Biochem J"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/ng871","article-title":"Defective prelamin A processing and muscular and adipocyte alterations in Zmpste24 metalloproteinase-deficient mice","volume":"31","author":"AM Pendas","year":"2002","journal-title":"Nat Genet"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1083\/jcb.200904124","article-title":"Role of A-type lamins in signaling, transcription, and chromatin organization","volume":"187","author":"V Andres","year":"2009","journal-title":"Journal of Cell Biology"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/6799","article-title":"Mutations in the gene encoding lamin A\/C cause autosomal dominant Emery-Dreifuss muscular dystrophy","volume":"21","author":"G Bonne","year":"1999","journal-title":"Nat Genet"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1056\/NEJM199912023412302","article-title":"Missense mutations in the rod domain of the lamin A\/C gene as causes of dilated cardiomyopathy and conduction-system disease","volume":"341","author":"D Fatkin","year":"1999","journal-title":"N Engl J Med"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1093\/hmg\/9.9.1453","article-title":"Identification of mutations in the gene encoding lamins A\/C in autosomal dominant limb girdle muscular dystrophy with atrioventricular conduction disturbances (LGMD1B)","volume":"9","author":"A Muchir","year":"2000","journal-title":"Hum Mol Genet"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1086\/339274","article-title":"Homozygous defects in LMNA, encoding lamin A\/C nuclear-envelope proteins, cause autosomal recessive axonal neuropathy in human (Charcot-Marie-Tooth disorder type 2) and mouse","volume":"70","author":"A De Sandre-Giovannoli","year":"2002","journal-title":"Am J Hum Genet"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/72807","article-title":"LMNA, encoding lamin A\/C, is mutated in partial lipodystrophy","volume":"24","author":"S Shackleton","year":"2000","journal-title":"Nat Genet"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"4835","DOI":"10.1210\/jc.2007-0654","article-title":"New metabolic phenotypes in laminopathies: LMNA mutations in patients with severe metabolic syndrome","volume":"92","author":"A Decaudain","year":"2007","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"3779","DOI":"10.1093\/hmg\/ddr294","article-title":"High prevalence of laminopathies among patients with metabolic syndrome","volume":"20","author":"A Dutour","year":"2011","journal-title":"Hum Mol Genet"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/nature01629","article-title":"Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome","volume":"423","author":"M Eriksson","year":"2003","journal-title":"Nature"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"R151","DOI":"10.1093\/hmg\/ddl214","article-title":"Molecular bases of progeroid syndromes","volume":"15","author":"CL Navarro","year":"2006","journal-title":"Hum Mol Genet"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1002\/ajmg.a.31346","article-title":"Hutchinson-Gilford progeria syndrome: review of the phenotype","volume":"140","author":"RC Hennekam","year":"2006","journal-title":"Am J Med Genet A"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1093\/hmg\/ddh265","article-title":"Lamin A and ZMPSTE24 (FACE-1) defects cause nuclear disorganization and identify restrictive dermopathy as a lethal neonatal laminopathy","volume":"13","author":"CL Navarro","year":"2004","journal-title":"Hum Mol Genet"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1093\/hmg\/ddi159","article-title":"Loss of ZMPSTE24 (FACE-1) causes autosomal recessive restrictive dermopathy and accumulation of Lamin A precursors","volume":"14","author":"CL Navarro","year":"2005","journal-title":"Hum Mol Genet"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1126\/science.1127168","article-title":"Lamin A-dependent nuclear defects in human aging","volume":"312","author":"P Scaffidi","year":"2006","journal-title":"Science"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1161\/CIRCULATIONAHA.109.902056","article-title":"Prelamin A acts to accelerate smooth muscle cell senescence and is a novel biomarker of human vascular aging","volume":"121","author":"CD Ragnauth","year":"2010","journal-title":"Circulation"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"a3172","DOI":"10.1136\/bmj.a3172","article-title":"HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity","volume":"338","author":"SG Deeks","year":"2009","journal-title":"Bmj"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1146\/annurev-med-042909-093756","article-title":"HIV infection, inflammation, immunosenescence, and aging","volume":"62","author":"SG Deeks","year":"2011","journal-title":"Annu Rev Med"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1210\/jc.2011-1159","article-title":"Clinical review#: Lipodystrophies: genetic and acquired body fat disorders","volume":"96","author":"A Garg","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1093\/cid\/cir627","article-title":"Premature age-related comorbidities among HIV-infected persons compared with the general population","volume":"53","author":"G Guaraldi","year":"2011","journal-title":"Clin Infect Dis"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"8818","DOI":"10.1128\/JVI.75.18.8818-8830.2001","article-title":"Fate of the inner nuclear membrane protein lamin B receptor and nuclear lamins in herpes simplex virus type 1 infection","volume":"75","author":"ES Scott","year":"2001","journal-title":"J Virol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1126\/science.1071506","article-title":"Cytomegalovirus recruitment of cellular kinases to dissolve the nuclear lamina","volume":"297","author":"W Muranyi","year":"2002","journal-title":"Science"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1126\/science.1063957","article-title":"Dynamic disruptions in nuclear envelope architecture and integrity induced by HIV-1 Vpr","volume":"294","author":"CM de Noronha","year":"2001","journal-title":"Science"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"13432","DOI":"10.1073\/pnas.0704212104","article-title":"HIV protease inhibitors block the zinc metalloproteinase ZMPSTE24 and lead to an accumulation of prelamin A in cells","volume":"104","author":"C Coffinier","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"9797","DOI":"10.1074\/jbc.M709629200","article-title":"A potent HIV protease inhibitor, darunavir, does not inhibit ZMPSTE24 or lead to an accumulation of farnesyl-prelamin A in cells","volume":"283","author":"C Coffinier","year":"2008","journal-title":"Journal of Biological Chemistry"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"e10874","DOI":"10.1371\/journal.pone.0010874","article-title":"Dynamics of lamin-A processing following precursor accumulation","volume":"5","author":"Q Liu","year":"2010","journal-title":"PLoS ONE"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1161\/ATVBAHA.110.213603","article-title":"Premature senescence of vascular cells is induced by HIV protease inhibitors: implication of prelamin A and reversion by statin","volume":"30","author":"C Lefevre","year":"2010","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/QAI.0b013e31815aba1b","article-title":"LMNA messenger RNA expression in highly active antiretroviral therapy-treated HIV-positive patients","volume":"46","author":"M Miranda","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1038\/sj.cdd.4402197","article-title":"Human lipodystrophies linked to mutations in A-type lamins and to HIV protease inhibitor therapy are both associated with prelamin A accumulation, oxidative stress and premature cellular senescence","volume":"14","author":"M Caron","year":"2007","journal-title":"Cell Death Differ"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1016\/j.ajpath.2011.07.049","article-title":"LMNA mutations induce a non-inflammatory fibrosis and a brown fat-like dystrophy of enlarged cervical adipose tissue","volume":"179","author":"V Bereziat","year":"2011","journal-title":"Am J Pathol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"e41129","DOI":"10.1371\/journal.pone.0041129","article-title":"HIV-1 Infection and First Line ART Induced Differential Responses in Mitochondria from Blood Lymphocytes and Monocytes: The ANRS EP45 \u201cAging\u201d Study","volume":"7","author":"S Perrin","year":"2012","journal-title":"PLoS One"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S1570-0232(02)00728-6","article-title":"Simultaneous quantitative determination of the HIV protease inhibitors indinavir, amprenavir, ritonavir, lopinavir, saquinavir, nelfinavir and the nelfinavir active metabolite M8 in plasma by liquid chromatography","volume":"783","author":"US Justesen","year":"2003","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1570-0232(04)00580-X","article-title":"Determination of the new HIV-protease inhibitor atazanavir by liquid chromatography after solid-phase extraction","volume":"810","author":"S Colombo","year":"2004","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S1570-0232(02)00169-1","article-title":"Determination of lopinavir and nevirapine by high-performance liquid chromatography after solid-phase extraction: application for the assessment of their transplacental passage at delivery","volume":"774","author":"C Marzolini","year":"2002","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0378-4347(97)00454-4","article-title":"Determination of ritonavir, a new HIV protease inhibitor, in biological samples using reversed-phase high-performance liquid chromatography","volume":"704","author":"KC Marsh","year":"1997","journal-title":"J Chromatogr B Biomed Sci Appl"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0378-4347(98)00392-2","article-title":"Simultaneous quantitative determination of the HIV protease inhibitors amprenavir, indinavir, nelfinavir, ritonavir and saquinavir in human plasma by ion-pair high-performance liquid chromatography with ultraviolet detection","volume":"719","author":"RP van Heeswijk","year":"1998","journal-title":"J Chromatogr B Biomed Sci Appl"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1097\/FTD.0b013e3181c05adf","article-title":"Validation of an electrospray ionization LC-MS\/MS method for quantitative analysis of raltegravir, etravirine, and 9 other antiretroviral agents in human plasma samples","volume":"31","author":"S Quaranta","year":"2009","journal-title":"Ther Drug Monit"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/nm1786","article-title":"Combined treatment with statins and aminobisphosphonates extends longevity in a mouse model of human premature aging","volume":"14","author":"I Varela","year":"2008","journal-title":"Nat Med"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1097\/00002030-200311210-00005","article-title":"Some HIV protease inhibitors alter lamin A\/C maturation and stability, SREBP-1 nuclear localization and adipocyte differentiation","volume":"17","author":"M Caron","year":"2003","journal-title":"Aids"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1021\/ar7001232","article-title":"Design of HIV protease inhibitors targeting protein backbone: an effective strategy for combating drug resistance","volume":"41","author":"AK Ghosh","year":"2008","journal-title":"Acc Chem Res"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.bbrc.2008.07.033","article-title":"HIV-protease inhibitors block the enzymatic activity of purified Ste24p","volume":"374","author":"SE Hudon","year":"2008","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"ref49","unstructured":"Yeni (2010) Prise en charge m\u00e9dicale des personnes infect\u00e9es par le VIH. ISBN : 978\u20132-11\u2013008038\u20137. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.sante.gouv.fr\/rapport-2010-sur-la-prise-en-charge-medicale-des-personnes-infectees-par-le-vih-sous-la-direction-du-pr-patrick-yeni.html\" xlink:type=\"simple\">http:\/\/www.sante.gouv.fr\/rapport-2010-sur-la-prise-en-charge-medicale-des-personnes-infectees-par-le-vih-sous-la-direction-du-pr-patrick-yeni.html<\/ext-link>. Accessed: 2012 Jun 21."},{"key":"ref50","doi-asserted-by":"crossref","unstructured":"Arab-Alameddine M, Decosterd LA, Buclin T, Telenti A, Csajka C (2011) Antiretroviral drug toxicity in relation to pharmacokinetics, metabolic profile and pharmacogenetics. Expert Opin Drug Metab Toxicol.","DOI":"10.1517\/17425255.2011.562891"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2165\/11318110-000000000-00000","article-title":"Intracellular Pharmacokinetics of Antiretroviral Drugs in HIV-Infected Patients, and their Correlation with Drug Action","volume":"49","author":"C Bazzoli","year":"2010","journal-title":"Clin Pharmacokinet"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1093\/jac\/dkh487","article-title":"The intracellular pharmacology of antiretroviral protease inhibitors","volume":"54","author":"J Ford","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1089\/088922203769232629","article-title":"Protein binding in antiretroviral therapies","volume":"19","author":"M Boffito","year":"2003","journal-title":"AIDS Res Hum Retroviruses"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/bjp.2008.320","article-title":"Cultured CD4T cells and primary human lymphocytes express hOATPs: intracellular accumulation of saquinavir and lopinavir","volume":"155","author":"O Janneh","year":"2008","journal-title":"Br J Pharmacol"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/FPC.0b013e328335b02d","article-title":"HIV protease inhibitors are substrates for OATP1A2, OATP1B1 and OATP1B3 and lopinavir plasma concentrations are influenced by SLCO1B1 polymorphisms","volume":"20","author":"RC Hartkoorn","year":"2010","journal-title":"Pharmacogenet Genomics"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1002\/jmv.21152","article-title":"Expression levels of MDR1, MRP1, MRP4, and MRP5 in peripheral blood mononuclear cells from HIV infected patients failing antiretroviral therapy","volume":"80","author":"O Turriziani","year":"2008","journal-title":"J Med Virol"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.2165\/00003495-200666090-00012","article-title":"Lopinavir\/ritonavir: a review of its use in the management of HIV infection","volume":"66","author":"V Oldfield","year":"2006","journal-title":"Drugs"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S1567-7249(02)00042-9","article-title":"In vitro evidence of inhibition of mitochondrial protease processing by HIV-1 protease inhibitors in yeast: a possible contribution to lipodystrophy syndrome","volume":"1","author":"A Mukhopadhyay","year":"2002","journal-title":"Mitochondrion"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1310\/WMWL-6W9Y-PXV2-X148","article-title":"Differences in the detection of three HIV-1 protease inhibitors in non-blood compartments: clinical correlations","volume":"3","author":"A Lafeuillade","year":"2002","journal-title":"HIV Clin Trials"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"4089","DOI":"10.1128\/AAC.00419-09","article-title":"Antiretroviral Tissue Kinetics: In Vivo Imaging Using Positron Emission Tomography","volume":"53","author":"M Di Mascio","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1126\/science.334.6063.1614","article-title":"HIV\/AIDS research. Tissue says blood is misleading, confusing HIV cure efforts","volume":"334","author":"J Cohen","year":"2011","journal-title":"Science"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"112re114","DOI":"10.1126\/scitranslmed.3003174","article-title":"Penetration of Tenofovir and Emtricitabine in Mucosal Tissues: Implications for Prevention of HIV-1 Transmission","volume":"3","author":"KB Patterson","year":"2011","journal-title":"Science Translational Medicine"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"3998","DOI":"10.1128\/AAC.00625-06","article-title":"Long-term treatment with lopinavir-ritonavir induces a reduction in peripheral adipose depots in mice","volume":"50","author":"M Prot","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/S0140-6736(02)08094-7","article-title":"Association between altered expression of adipogenic factor SREBP1 in lipoatrophic adipose tissue from HIV-1-infected patients and abnormal adipocyte differentiation and insulin resistance","volume":"359","author":"JP Bastard","year":"2002","journal-title":"Lancet"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.2337\/diabetes.50.6.1378","article-title":"The HIV protease inhibitor indinavir impairs sterol regulatory element-binding protein-1 intranuclear localization, inhibits preadipocyte differentiation, and induces insulin resistance","volume":"50","author":"M Caron","year":"2001","journal-title":"Diabetes"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1097\/01.aids.0000186827.91408.90","article-title":"HIV protease inhibitors block adipocyte differentiation independently of lamin A\/C","volume":"19","author":"BA Kudlow","year":"2005","journal-title":"Aids"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1093\/hmg\/ddi480","article-title":"Nuclear lamin A inhibits adipocyte differentiation: implications for Dunnigan-type familial partial lipodystrophy","volume":"15","author":"RL Boguslavsky","year":"2006","journal-title":"Hum Mol Genet"}],"updated-by":[{"DOI":"10.1371\/annotation\/f02cdfd3-b271-46fd-a78f-5a030f0b416d","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2013,8,14]],"date-time":"2013-08-14T00:00:00Z","timestamp":1376438400000}}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0053035","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,7]],"date-time":"2019-07-07T17:42:57Z","timestamp":1562521377000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0053035"}},"subtitle":[],"editor":[{"given":"Clive M.","family":"Gray","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,12,28]]},"references-count":67,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2012,12,28]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0053035","relation":{"correction":[{"id-type":"doi","id":"10.1371\/annotation\/f02cdfd3-b271-46fd-a78f-5a030f0b416d","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,28]]}}}